APA (7th ed.) Citation

SP, C., J, Y., IB, P., SJ, K., SW, P., CH, L., . . . T, C. (2026). Targeting MAFB potentiates immune checkpoint inhibitor efficacy by reprogramming tumor-associated macrophages to an M1-like phenotype in colorectal cancer. Translational research : the journal of laboratory and clinical medicine, 289, 27. https://doi.org/10.1016/j.trsl.2026.02.006

Chicago Style (17th ed.) Citation

SP, Choi, et al. "Targeting MAFB Potentiates Immune Checkpoint Inhibitor Efficacy by Reprogramming Tumor-associated Macrophages to an M1-like Phenotype in Colorectal Cancer." Translational Research : The Journal of Laboratory and Clinical Medicine 289 (2026): 27. https://doi.org/10.1016/j.trsl.2026.02.006.

MLA (9th ed.) Citation

SP, Choi, et al. "Targeting MAFB Potentiates Immune Checkpoint Inhibitor Efficacy by Reprogramming Tumor-associated Macrophages to an M1-like Phenotype in Colorectal Cancer." Translational Research : The Journal of Laboratory and Clinical Medicine, vol. 289, 2026, p. 27, https://doi.org/10.1016/j.trsl.2026.02.006.